1887
  1. Home
  2. A-Z Publications
  3. Qatar Medical Journal
  4. Volume 2005, Issue 2
  5. Article
Volume 2005, Issue 2
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Hemolytic uraemic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP) are described as acute syndromes with multisystem abnormalities and pentad of thrombocytopenia, microangiopathic hemolysis, neurological symptoms, renal impairment and fever. Both diseases were believed to form a continuum of the same disease, but recently it was found, that they were having a different pathophysiology, as TTP patients have a deficiency in von wilbrand factor (vWF) cleavage protease. When renal involvement is severe with little or no neurological manifestation, this microangiopathy is termed as haemolytic-uraemic syndrome. If the hemolytic uraemic syndrome is not associated with diarrhoea, it is called Dnegative or atypical HUS. This subdivision is of etiological and prognostic importance. TTP-HUS is associated with high maternal and fetal morbidity and mortality. Treatment of these syndromes differs from syndrome of hemolysis with elevated liver enzymes (HE LLP syndrome) and acute fatty liver of pregnancy hence accurate diagnosis is important for optimal therapy. Plasma transfusion and plasmapheresis have revolutionized management of TTP and HUS by increasing survival 80% to 90%. Here we are reporting a case of D-negative hemolytic uraemic syndrome associated with pregnancy causing intrauterine fetal death. Diagnosis made on clinical and hematological findings, successfully treated by plasmapheresis with residual maternal renal impairment. We are presenting this case, as it is rare disorder associated with high mortality and morbidity, to increase awareness about disease, its diagnosis and management.

© 2005 Sheikh, Kettern, Ahmed, licensee Bloomsbury Qatar Foundation Journals.
Loading

Article metrics loading...

/content/journals/10.5339/qmj.2005.2.18
2005-11-01
2024-04-20
Loading full text...

Full text loading...

References

  1. Tsai HM. lian E,.Antibodies to von will brand factor cleavage protease in thrombotic thrombocytopenic purpura. N Eng J Med. 1998; 339::1585.
     [Google Scholar]
  2. Robert S, Egerman Andrea G, Steven A, Sibai MB. Thrombotic thrombocytopenic purpura and haemolytic uremic syndrome: Review of 11 cases. Am J obstet Gynecol. 1996; 175::950–956.
     [Google Scholar]
  3. Ridoffi RL, Bell WR. Thrombotic thrombocytic purpura: Report of 25 cases and review of literature. Medicine (Baltimore). 1981; 60::413–428.
     [Google Scholar]
  4. George JN. The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uraemic syndrome. Curr opin Hematol. 2003; 10::339.
     [Google Scholar]
  5. Furlan M, Robles R, Galbusera M. Von will brand factor cleaving protease in thrombotic thrombocytopenic purpura and hemolytic uraemic syndrome. Eng J med. 1998; 339::1578.
     [Google Scholar]
  6. Wun T, Bahuo WF. Thrombotic thrombocytopenic purpura. In http://www.emedicine.com/MED/topic 2265.htm.
  7. Gasser C, Galltier E, Steek A. Hemolytic-uremic syndrome: Bilateral necrosis of renal cortex in acute haemolytic anemia. Schweiz med wochenchr. 1955; 85::905.
     [Google Scholar]
  8. Fitzpatrick NM, Walters MDS, Trompeter FS, Atypical hemolytic uraemic syndrome in childhood pediatr. 1993; 122::532.
     [Google Scholar]
  9. Biega T, Prausser R. Hemolytic-uremic syndrome. In http://www.emedicine.com/MED/hmt .
  10. Wiener CP. Thrombotic microangiopathy in pregnancy and postpartum period. seim Hematol. 1987; 24::119–129.
     [Google Scholar]
  11. Davies GE. Thrombotic thrombocytopenic purpura in pregnancy with maternal survival: A case report. Br J obstet. 1984; 91::396–398.
     [Google Scholar]
  12. Onundarson PT, Rowe JM, Heal JM, Francis CW. Response to plasma exchange and spleenectomy in thrombotic thrombocytopenic purpura: A 10 years experience at single institution. Arch Int med. 1992; 152::791–796.
     [Google Scholar]
  13. Bell WR, Braine HG, Ness PM, Kicker TS. Improved in thrombotic thrombocytopenic purpura-hemolytic uraemic syndrome. Eng J med. 1991; 325::398–403.
     [Google Scholar]
  14. Levin M, Grunwald HW. Use of vincristine in refractory thrombotic thrombocytopenic purpura. Acta Hematol. 1999; 85::37–40.
     [Google Scholar]
  15. Moake JL, Rudy CK, Troll JH. Therapy for chronic relapsing thrombotic thrombocytopenic purpura with prednisolone and azathioprine. Am J Hematol. 1985; 20::73–79.
     [Google Scholar]
  16. George JN, EL Harake M. Thrombocytopenia due to enhance platelet destruction by non-immunological mech. In: Beutler ELichman MAColler BSKipps TJ, eds. Williams hematology. 5th ed. New York: McGraw Hill 1995:p.1290.
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2005.2.18
Loading
  • Article Type: Case Report
Keyword(s): fatty liver, HELLP syndrome, hemolytic uremic syndrome, Microangiopathies, plasmapheresis and thrombotic thrombocytic purpura

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error